Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.4589
Delayed Data
As of Jul 26
 0.00 / 0.00%
Today’s Change
0.45
Today|||52-Week Range
12.19
-85.66%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close0.46
Today’s openn.a.
Day’s range-- - --
Volume270
Average volume (3 months)713,426
Market cap$52.1M
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)+35.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+19.60%
P/E ratioNM
Price/Sales143.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp0.000.00%
AVIRAviragen Therapeutic...0.000.00%
NTECIntec Pharma Ltd0.000.00%
AMPEAmpio Pharmaceutical...-0.00-0.25%
Data as of 07/26/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.7M
Annual profit (last year)-$114.7M
Net profit margin-6,598.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer &
Secretary
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

Partner Offers

Search for Jobs